Gene expression profiling in PC12 cells infected with an oncolytic Newcastle disease virus strain

András Balogh1, Judit Bátor1, Lajos Markó2

  • 1Department of Medical Biology, University of Pécs Medical School, Pécs, Hungary; Signal Transduction Research Group, János Szentágothai Research Centre, Pécs H-7624, Hungary.

Virus Research
|March 19, 2014
PubMed

Insights

Newcastle disease virus (NDV) can infect tumor cells, but understanding why some are susceptible is key. This study identified gene expression changes in PC12 cells after NDV infection, revealing potential markers for predicting tumor treatment success.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Newcastle disease virus (NDV) exhibits oncolytic potential, yet the cellular mechanisms dictating tumor cell susceptibility remain largely unknown.
  • Understanding these mechanisms is crucial for advancing NDV-based virotherapeutics.

Purpose of the Study:

  • To investigate gene expression alterations in PC12 pheochromocytoma cells upon infection with an attenuated NDV strain (MTH-68/H).
  • To identify genes and pathways associated with NDV susceptibility in tumor cells.

Main Methods:

  • PC12 cells were infected with NDV strain MTH-68/H.
  • Gene expression profiling was performed using Affymetrix exon arrays.
  • Quantitative reverse transcriptase PCR (qRT-PCR) was used for validation.
  • DAVID functional annotation clustering was employed for pathway analysis.

Main Results:

  • A total of 729 genes were upregulated and 612 genes were downregulated in NDV-infected PC12 cells.
  • Significant changes were observed in key signaling pathways including Toll-like receptor, RIG-I-like receptor, interferon signaling, apoptosis, endoplasmic reticulum stress, and cell cycle regulation.
  • Expression changes in 9 specific genes were validated via qRT-PCR.

Conclusions:

  • NDV infection induces significant gene expression changes in PC12 cells, impacting multiple regulatory pathways.
  • These identified gene expression profiles and proteins may serve as susceptibility markers for predicting the efficacy of NDV-based virotherapy in human tumors.
  • Further research into these proteins could refine patient selection for virotherapeutic treatments.

Related Concept Videos